238 related articles for article (PubMed ID: 28078633)
21. Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis.
Imfeld P; Bodmer M; Schuerch M; Jick SS; Meier CR
Epilepsia; 2013 Apr; 54(4):700-7. PubMed ID: 23215680
[TBL] [Abstract][Full Text] [Related]
22. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study.
Tolppanen AM; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
BMJ Open; 2016 Jul; 6(7):e012100. PubMed ID: 27412109
[TBL] [Abstract][Full Text] [Related]
23. Influenza infections and risk of Alzheimer's disease.
Imfeld P; Toovey S; Jick SS; Meier CR
Brain Behav Immun; 2016 Oct; 57():187-192. PubMed ID: 27006278
[TBL] [Abstract][Full Text] [Related]
24. Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medications.
Dublin S; Rossing MA; Heckbert SR; Goff BA; Weiss NS
Cancer Causes Control; 2002 Feb; 13(1):35-45. PubMed ID: 11899116
[TBL] [Abstract][Full Text] [Related]
25. Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study.
Imfeld P; Bodmer M; Jick SS; Meier CR
J Am Geriatr Soc; 2012 May; 60(5):916-21. PubMed ID: 22458300
[TBL] [Abstract][Full Text] [Related]
26. Association Between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Older Persons With Alzheimer's Disease.
Won DY; Byun SJ; Jeong JS; Shin JY
J Am Med Dir Assoc; 2020 Aug; 21(8):1128-1133.e1. PubMed ID: 31926798
[TBL] [Abstract][Full Text] [Related]
27. Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study.
Törmälehto S; Martikainen J; Bell JS; Hallikainen I; Koivisto AM
Int Psychogeriatr; 2017 Oct; 29(10):1723-1733. PubMed ID: 28625207
[TBL] [Abstract][Full Text] [Related]
28. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease.
Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S
CMAJ; 2017 Apr; 189(14):E519-E529. PubMed ID: 28396328
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
Cumbo E; Ligori LD
J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
[TBL] [Abstract][Full Text] [Related]
30. Association Between Lithium Use and Risk of Alzheimer's Disease.
Cheng C; Zandi P; Stuart E; Lin CH; Su PY; Alexander GC; Lan TH
J Clin Psychiatry; 2017 Feb; 78(2):e139-e145. PubMed ID: 28002662
[TBL] [Abstract][Full Text] [Related]
31. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tolppanen AM; Sund R; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2017 May; 32(3):135-141. PubMed ID: 28072593
[TBL] [Abstract][Full Text] [Related]
32. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R
Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032
[TBL] [Abstract][Full Text] [Related]
33. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2015 Jul; 30(4):202-8. PubMed ID: 26011780
[TBL] [Abstract][Full Text] [Related]
34. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
[TBL] [Abstract][Full Text] [Related]
35. Rheumatoid Arthritis Was Negatively Associated with Alzheimer's Disease: A Population-Based Case-Control Study.
Kao LT; Kang JH; Lin HC; Huang CC; Lee HC; Chung SD
PLoS One; 2016; 11(12):e0168106. PubMed ID: 27997574
[TBL] [Abstract][Full Text] [Related]
36. Effective pharmacological management of Alzheimer's disease.
Atri A
Am J Manag Care; 2011 Nov; 17 Suppl 13():S346-55. PubMed ID: 22214392
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for Alzheimer's disease in Russia: a case-control study.
Suhanov AV; Pilipenko PI; Korczyn AD; Hofman A; Voevoda MI; Shishkin SV; Simonova GI; Nikitin YP; Feigin VL
Eur J Neurol; 2006 Sep; 13(9):990-5. PubMed ID: 16930366
[TBL] [Abstract][Full Text] [Related]
38. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
[TBL] [Abstract][Full Text] [Related]
39. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland.
Laitinen ML; Bell JS; Lavikainen P; Lönnroos E; Sulkava R; Hartikainen S
Int Psychogeriatr; 2011 Dec; 23(10):1623-31. PubMed ID: 21867581
[TBL] [Abstract][Full Text] [Related]
40. Five-year trajectories of long-term benzodiazepine use by adolescents: patient, provider, and medication factors.
Yeh HH; Chen CY; Fang SY; Chang IS; Wu EC; Lin KM
Psychiatr Serv; 2011 Aug; 62(8):900-7. PubMed ID: 21807829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
